The global biomaterials market size is expected to reach USD 488.71 billion by 2030, registering a CAGR of 15.52% over the forecast period, according to a new report by Grand View Research, Inc. The application of biomaterials represents a fast-growing field in biomedical research. Recent advances in the improvement of bioactivity, compatibility, and mechanical properties of biomaterials have introduced new opportunities for their application in tissue engineering, immune engineering, and drug delivery systems.
Biomaterials Market Report Highlights
- High availability of natural and synthetic degradable polymers and their wide usage as surgical sutures and implants resulted in the largest revenue share of the polymers product segment
- Natural products have gained immense popularity as a source of novel bioactive substance for the development of novel drugs, leading to fastest growth of this segment
- Increasing incidence of chronic skeletal and musculoskeletal conditions is expected to raise the demand for biomaterials for orthopedics application at a large scale
- The infection from coronavirus, that is, SARS-COV-2 can be detected using existing biomedical devices which are based on either Polymerase Chain Reaction (PCR) or Non-PCR methods
- Improvement in the surface modification of silicone breast implants to prevent capsular contracture is one of the factors driving the biomaterial usage in the plastic surgery segment at the fastest rate
- Biosensor, is an analytical device that is used to detect analytes such as biomolecules or biological elements of species produced by micro-organisms, that is tissues, enzymes, and organelles
- North America is expected to dominate the market in terms of revenue share owing to the presence of public and private agencies promoting biomaterial usage by hosting events and funding initiatives
- Asia Pacific is anticipated to grow at a rapid pace owing to the presence of several local manufacturers developing low-cost biomaterial products, mainly in China
- Prominent players operating in the market include Medtronic, Evonik, DSM, BASF, Berkeley Advanced Biomaterials, Covalon Technologies, and Zimmer Biomet Holdings
- Companies are engaged in several strategic growth initiatives, such as novel product developments, partnerships, and regional expansion to reinforce their market presence
- For instance, in March 2022, Medtronic announced a collaboration with Vizient to add Touch Surgery Enterprise to Vizient’s portfolio, which is an AI-powered video management and analytical platform that provides surgical teams with simple access to procedural recordings and insights
Gain deeper insights on the market and receive your free copy with TOC now @: Biomaterials Market Report
Biomaterials are materials that are specifically designed and engineered to interact with biological systems, such as living tissues and organs. They are used in various fields of medicine and healthcare to develop medical devices, implants, and regenerative therapies. Biomaterials can be synthetic or natural in origin and possess unique properties that allow them to be compatible with the human body, promoting healing, regeneration, or providing mechanical support. They are extensively researched and tailored to meet specific biomedical requirements, including biocompatibility, bioactivity, durability, and controlled degradation. Biomaterials play a crucial role in advancing medical treatments and improving patient outcomes by providing innovative solutions for repairing and replacing damaged or diseased tissues and organs.
The integration of 3D printing technology with biomaterials has revolutionized the field of tissue engineering and regenerative medicine. Researchers have made significant progress in printing complex, functional structures using biomaterials, enabling the creation of patient-specific implants, scaffolds, and organs. The ability to print with multiple materials and incorporate cells and growth factors has opened new possibilities for customized biomedical solutions. There has been a growing emphasis on developing biomaterials that are biodegradable and bioresorbable. These materials can degrade and be absorbed by the body over time, reducing the need for additional surgical procedures. Biodegradable polymers and scaffold materials have found applications in areas such as drug delivery systems, orthopedics, and wound healing. The development of smart biomaterials involves incorporating responsive elements, such as sensors, actuators, and drug release systems, into the material matrix. These materials can sense changes in their environment and respond accordingly. For example, smart hydrogels can change their properties in response to temperature, pH, or electrical signals, enabling controlled drug release or tissue engineering applications.
Nanotechnology has made significant contributions to the field of biomaterials, enabling precise control at the nanoscale. Nanomaterials offer unique properties, such as increased surface area, improved mechanical strength, and enhanced bioactivity. They have been used in applications ranging from drug delivery systems to tissue engineering scaffolds, allowing for better control over cellular interactions and tissue regeneration. Researchers are increasingly drawing inspiration from nature to develop biomaterials with enhanced properties. For example, biomaterials mimicking the structure and properties of natural tissues, such as bone or cartilage, have shown promise in promoting tissue regeneration. Bio-inspired materials also seek to replicate the dynamic and responsive characteristics found in living systems, leading to innovative approaches in wound healing, drug delivery, and tissue engineering.
Surface modification techniques are being explored to improve the biocompatibility and functionality of biomaterials. These techniques involve altering the surface properties of biomaterials at the nanoscale to enhance cellular interactions, reduce inflammation, and prevent infections. Surface modifications can include the incorporation of bioactive molecules, such as growth factors or antimicrobial agents, or the creation of nanostructures that promote specific cellular responses.
Biocompatibility, low toxicity, and renewable nature of polymeric biomaterials make them potent drug delivery agents in controlled and targeted drug delivery, thus providing lucrative opportunities for the market growth. The advent of improved drug delivery approaches, such as PEG-coated liposomes, biopolymer-coated liposomes, and nanomaterials drug delivery, further expands the prospects of these biopolymers in the pharmaceutical and medical industries.
Use of biomaterials has greatly benefited the regeneration of the cardiopulmonary system. These materials provide physical support and physiological and chemical cues to seeded cells to assist the tissue regeneration process. Integration of biomaterials with nanotechnology techniques also stimulates the regeneration of damaged cardiomyocytes’ extracellular matrix, thus replacing the traditional organ transplantation procedures.
For More Details or Sample Copy please visit link @: https://www.grandviewresearch.com/industry-analysis/biomaterials-industry/request/rs1
Biomaterials Market Insights By Region
North America accounted for the largest share owing to the initiatives undertaken by several public and private organizations. These include the National Science Foundation and the National Institute of Standards and Technology, which provide knowledge and assistance pertaining to biomaterials usage in biomedical applications. This has resulted in the expansion of biomaterials adoption in this region. Factors such as favorable government policies and the presence of several major market players in this region have contributed to the regional market share. Asia Pacific is expected to register the highest growth, owing to strategic initiatives adopted by the regional participants to reinforce their presence in local as well as global markets. In India, the biomaterials market is constantly booming. The Indian biomaterials industry is dominated by orthopedic, dental, and cardiovascular biomaterials. Increasing market shares of cardiovascular and orthopedic and biomaterial products are due to an increase in orthopedic surgery, cardiovascular surgeries, and dental procedures.
Competitive Analysis By Major Companies
Key companies are making significant investments to expand their presence and maintain a competitive edge. They are also adopting strategies such as agreements, partnerships, and collaboration models to strengthen their product portfolio. Key vendors are inclined toward the development of more innovative products to expand their biomaterials offerings. Some of the prominent companies in the global biomaterials market include:
- Medtronic plc
- Evonik Industries AG
- Carpenter Technology Corporation
- Berkeley Advanced Biomaterials
- Invibio Ltd.
- Zimmer Biomet Holdings, Inc.
- BASF SE
Grand View Research has segmented the global biomaterials market on the basis of product, application, and region.
Research Methodology
We employ a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecasts possible. We utilize a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created and customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.
For Customized reports or Special Pricing please visit @: https://www.grandviewresearch.com/checkout/select-license/biomaterials-industry
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S. based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Contact:
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll-Free: 1-888-202-9519
Email: [email protected]